CLEPSO 2018 Meeting - Poster & Abstract submission
* NOTE: EXTENDED ABSTRACT submission DEADLINE:
SUNDAY, February 18h, 2018
Abstracts should describe any original research that advances or illuminates any topic with a link to clinical epigenetics. Case reports and studies on animal human disease models are also welcome.
Upon submission, the scientific committee will judge abstracts for suitability. Authors of selected posters will be notified by email. Authors are permitted to submit more than one abstract. Abstracts should be in English, contain no more than 300 words. Each abstract should also include a brief title. Abbreviations should be kept to a minimum and defined after first use. Tables, figures, and references are not allowed in the abstract, but may be included on posters.
The full names, affiliation(s), and full address(es) of all authors should be provided. The name and address of the authors who will both present the poster and act as the corresponding author during the selection stage should be clearly indicated at submission, together with contact details. All authors should disclose any financial or personal relationship with people or organisations that could be perceived to bias their work. All sources of funding should also be declared. Abstract title, names and addresses of authors, contact details, conflicts of interest declarations, and descriptions of the funding source(s) do not count towards the word limit. Abstracts should be proofread for accuracy before submission.
The maximum poster size is 84 cm in height und 115 cm in width (DIN A0).
Abstracts should be submitted by Sunday, January 14th, 2018 via email to:
e-mail : email@example.com
No Show Policy:
Please notify the CLEPSO office as early as possible if your oral or poster presentation will not be made. If a scheduled presenter fails to appear in person or to send a replacement, and does not cancel the poster or slide presentation at the latest 14 days before the meeting, that presenter will be barred from having an abstract accepted at the CLEPSO meeting and manuscripts being accepted by the Clinical Epigenetics journal for three years. Registration fees apply also if presentations that have been accepted and scheduled for presentation have not been retracted 14 days at the latest prior to the meeting.